|
US3828068A
(en)
|
1971-05-10 |
1974-08-06 |
Tenneco Chem |
((substituted indazolyl)-n1-methyl)carbamates
|
|
US4154943A
(en)
|
1977-12-29 |
1979-05-15 |
University Of Vermont |
Preparation of vincadifformine
|
|
FR2619111B1
(fr)
|
1987-08-07 |
1991-01-11 |
Synthelabo |
Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
|
|
CA2020437A1
(en)
|
1989-07-05 |
1991-01-06 |
Yoshihide Fuse |
Cinnamamide derivative
|
|
DE4126662A1
(de)
|
1991-08-13 |
1993-02-18 |
Boehringer Mannheim Gmbh |
Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
|
|
HU210679B
(en)
|
1991-11-21 |
1995-06-28 |
Richter Gedeon Vegyeszet |
Process for producing new tetrahydro-pyrido/3,4-b/indol derivatives and pharmaceutical compositions containing the same
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5416193A
(en)
|
1993-04-30 |
1995-05-16 |
Pfizer Inc. |
Coupling reagent and method
|
|
MA23420A1
(fr)
|
1994-01-07 |
1995-10-01 |
Smithkline Beecham Corp |
Antagonistes bicycliques de fibrinogene.
|
|
US5614551A
(en)
|
1994-01-24 |
1997-03-25 |
The Johns Hopkins University |
Inhibitors of fatty acid synthesis as antimicrobial agents
|
|
JPH10504808A
(ja)
|
1994-06-29 |
1998-05-12 |
スミスクライン・ビーチャム・コーポレイション |
ビトロネクチン受容体拮抗物質
|
|
US6176842B1
(en)
|
1995-03-08 |
2001-01-23 |
Ekos Corporation |
Ultrasound assembly for use with light activated drugs
|
|
US5989832A
(en)
|
1995-04-21 |
1999-11-23 |
Microcide Pharmaceuticals, Inc. |
Method for screening for non-tetracycline efflux pump inhibitors
|
|
DE69626389T2
(de)
|
1995-05-11 |
2003-10-09 |
Biochemie Ges.M.B.H., Kundl |
Antibakterielle cephalosporinverbindungen
|
|
US6057291A
(en)
|
1995-06-02 |
2000-05-02 |
University Of British Columbia |
Antimicrobial cationic peptides
|
|
JP3180350B2
(ja)
|
1996-02-29 |
2001-06-25 |
藤沢薬品工業株式会社 |
β―ラクタム系抗生物質含有錠剤およびその製造法
|
|
US6239154B1
(en)
|
1996-03-08 |
2001-05-29 |
Adolor Corporation |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
|
|
US6367985B1
(en)
|
1996-03-12 |
2002-04-09 |
Intellectual Property Company |
Optical connector using large diameter alignment features
|
|
US6451816B1
(en)
|
1997-06-20 |
2002-09-17 |
Klinge Pharma Gmbh |
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
|
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
US6503881B2
(en)
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
US6995254B1
(en)
|
1996-08-28 |
2006-02-07 |
Affinium Pharmaceuticals, Inc. |
Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I
|
|
BR9712072A
(pt)
|
1996-09-20 |
1999-08-24 |
Meiji Seika Kaisha |
Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma
|
|
US6521408B1
(en)
|
1997-09-25 |
2003-02-18 |
National Institute Of Agrobiological Sciences |
Method for assessing a function of a gene
|
|
DE19641437A1
(de)
|
1996-10-08 |
1998-04-09 |
Basf Ag |
1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung
|
|
DE19652239A1
(de)
|
1996-12-16 |
1998-06-18 |
Bayer Ag |
Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
|
|
SI9600371B
(sl)
|
1996-12-18 |
2005-04-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Etilidenski derivati tricikličnih karbapenemov
|
|
AU6870098A
(en)
|
1997-03-31 |
1998-10-22 |
Du Pont Merck Pharmaceutical Company, The |
Indazoles of cyclic ureas useful as hiv protease inhibitors
|
|
ATE389417T1
(de)
|
1997-04-01 |
2008-04-15 |
Borody Thomas J |
Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
|
|
US6406880B1
(en)
|
1997-05-02 |
2002-06-18 |
Integrated Research Technology, Llc |
Betaines as adjuvants to susceptibility testing and antimicrobial therapy
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
|
WO1998058928A1
(fr)
|
1997-06-23 |
1998-12-30 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Agent prophylactique ou therapeutique contre des maladies attribuables a une infection par des helicobacters
|
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
|
US6198000B1
(en)
|
1997-07-07 |
2001-03-06 |
Pfizer Inc. |
Intermediates useful in the synthesis of quinoline antibiotics
|
|
EP1000935A4
(en)
|
1997-07-25 |
2001-03-21 |
Tsumura & Co |
PYRIDYL ACRYLAMIDE DERIVATIVES AND DRUGS AGAINST NEPHRITIS AND INHIBITORS OF THE TRANSFORMING GROWTH FACTOR BETA CONTAINING THESE DERIVATIVES
|
|
HN1998000106A
(es)
|
1997-08-01 |
1999-01-08 |
Pfizer Prod Inc |
Composiciones parenterales de alatroflaxacino
|
|
US5932743A
(en)
|
1997-08-21 |
1999-08-03 |
American Home Products Corporation |
Methods for the solid phase synthesis of substituted indole compounds
|
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
|
RU2224024C2
(ru)
|
1997-10-31 |
2004-02-20 |
Зингента Партисипейшнс Аг |
Трансгенные растения
|
|
US6432444B1
(en)
|
1997-10-31 |
2002-08-13 |
New Horizons Diagnostics Corp |
Use of bacterial phage associated lysing enzymes for treating dermatological infections
|
|
ATE231841T1
(de)
|
1997-11-07 |
2003-02-15 |
Schering Corp |
Phenyl-alkyl imidazole als h3 rezeptor antagonisten
|
|
SE9704404D0
(sv)
|
1997-11-28 |
1997-11-28 |
Astra Ab |
New compounds
|
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
|
DE19753298A1
(de)
|
1997-12-01 |
1999-06-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
|
EP1051978B1
(en)
|
1998-01-07 |
2012-08-22 |
Meiji Seika Pharma Co., Ltd. |
Crystallographically stable amorphous cephalosporin compositions and process for producing the same
|
|
US6184380B1
(en)
|
1999-01-25 |
2001-02-06 |
Pfizer Inc. |
Process for preparing naphthyridones and intermediates
|
|
US6248343B1
(en)
|
1998-01-20 |
2001-06-19 |
Ethicon, Inc. |
Therapeutic antimicrobial compositions
|
|
PA8466701A1
(es)
|
1998-01-21 |
2000-09-29 |
Pfizer Prod Inc |
Comprimido de mesilato de trovafloxacino
|
|
US6204279B1
(en)
|
1998-06-03 |
2001-03-20 |
Microcide Pharmaceuticals, Inc. |
Peptidomimetic efflux pump inhibitors
|
|
US6503539B2
(en)
|
1998-02-27 |
2003-01-07 |
Biora Bioex Ab |
Matrix protein compositions for wound healing
|
|
US6350738B1
(en)
|
1998-03-06 |
2002-02-26 |
Brigham Young University |
Steroid derived antibiotics
|
|
US6369049B1
(en)
|
1998-04-30 |
2002-04-09 |
Eli Lilly And Company |
Treatment of mastitis
|
|
DE19820801A1
(de)
|
1998-05-09 |
1999-11-25 |
Gruenenthal Gmbh |
Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
|
|
DE19821039A1
(de)
|
1998-05-11 |
1999-11-18 |
Bayer Ag |
Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
|
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
US6428579B1
(en)
|
1998-07-01 |
2002-08-06 |
Brown University Research Foundation |
Implantable prosthetic devices coated with bioactive molecules
|
|
US6423741B1
(en)
|
1998-07-10 |
2002-07-23 |
Council Of Scientific And Industrial Research |
Anti-microbial composition and method for producing the same
|
|
GB9815567D0
(en)
|
1998-07-18 |
1998-09-16 |
Glaxo Group Ltd |
Antiviral compound
|
|
PT1101497E
(pt)
|
1998-08-04 |
2008-04-23 |
Schering Plough Animal Health |
Preparações oleosas estabilizadas de tobicilina (antibiótico beta-lactâmico)
|
|
CN1133432C
(zh)
|
1998-08-21 |
2004-01-07 |
千寿制药株式会社 |
含水液体药物组合物
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
US6518487B1
(en)
|
1998-09-23 |
2003-02-11 |
Pioneer Hi-Bred International, Inc. |
Cyclin D polynucleotides, polypeptides and uses thereof
|
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
|
US6395746B1
(en)
|
1998-09-30 |
2002-05-28 |
Alcon Manufacturing, Ltd. |
Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
|
|
DE19851104C2
(de)
|
1998-11-06 |
2003-04-03 |
Huhtamaki Forchheim |
Verfahren zum Herstellen eines mehrschichtigen Verbundes
|
|
TW526202B
(en)
|
1998-11-27 |
2003-04-01 |
Shionogi & Amp Co |
Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
|
|
AU768957B2
(en)
|
1999-02-18 |
2004-01-08 |
Regents Of The University Of California, The |
Phthalamide-lanthanide complexes for use as luminescent markers
|
|
US6235728B1
(en)
|
1999-02-19 |
2001-05-22 |
Bristol-Myers Squibb Company |
Water-soluble prodrugs of azole compounds
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
AU3615200A
(en)
|
1999-03-03 |
2000-09-21 |
Princeton University |
Bacterial transglycosylases: assays for monitoring the activity using lipid ii substrate analogs and methods for discovering new antibiotics
|
|
US6495161B1
(en)
|
1999-03-09 |
2002-12-17 |
Vivorx, Inc. |
Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
US6224579B1
(en)
|
1999-03-31 |
2001-05-01 |
The Trustees Of Columbia University In The City Of New York |
Triclosan and silver compound containing medical devices
|
|
AU4230900A
(en)
|
1999-04-08 |
2000-10-23 |
General Hospital Corporation, The |
Purposeful movement of human migratory cells away from an agent source
|
|
CO5180550A1
(es)
|
1999-04-19 |
2002-07-30 |
Smithkline Beecham Corp |
Inhibidores de fab i
|
|
US6290946B1
(en)
|
1999-05-13 |
2001-09-18 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders and antibacterial agents
|
|
US6514535B2
(en)
|
1999-05-21 |
2003-02-04 |
Noveon Ip Holdings Corp. |
Bioadhesive hydrogels with functionalized degradable crosslinks
|
|
AR024077A1
(es)
|
1999-05-25 |
2002-09-04 |
Smithkline Beecham Corp |
Compuestos antibacterianos
|
|
CO5370679A1
(es)
|
1999-06-01 |
2004-02-27 |
Smithkline Beecham Corp |
Inhibidores fab 1
|
|
US6239141B1
(en)
|
1999-06-04 |
2001-05-29 |
Pfizer Inc. |
Trovafloxacin oral suspensions
|
|
CO5180605A1
(es)
|
1999-06-23 |
2002-07-30 |
Smithkline Beecham Corp |
Compuestos de indol
|
|
CA2282066C
(en)
|
1999-06-29 |
2010-09-07 |
Smithkline Beecham Corporation |
Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
US6346391B1
(en)
|
1999-07-22 |
2002-02-12 |
Trustees Of Tufts College |
Methods of reducing microbial resistance to drugs
|
|
EP1212093B1
(en)
|
1999-08-26 |
2004-07-07 |
Ganeden Biotech, Inc. |
Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
|
|
US6221859B1
(en)
|
1999-08-27 |
2001-04-24 |
Merck & Co., Inc. |
Carbapenem antibacterial compositions and methods of the treatment
|
|
US6174878B1
(en)
|
1999-08-31 |
2001-01-16 |
Alcon Laboratories, Inc. |
Topical use of kappa opioid agonists to treat otic pain
|
|
CN1373674A
(zh)
|
1999-09-11 |
2002-10-09 |
宝洁公司 |
易流动液体载体
|
|
DE60025503T2
(de)
|
1999-09-17 |
2006-09-07 |
Daiichi Asubio Pharma Co., Ltd. |
Pharmazeutische Zusammensetzungen, die Faropenem-Natrium und eine Diaminoacetat Verbindung zur Verbesserung der Magen-Darm-Trakt Absorption enthalten
|
|
US6500463B1
(en)
|
1999-10-01 |
2002-12-31 |
General Mills, Inc. |
Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
|
|
US6730684B1
(en)
|
1999-10-08 |
2004-05-04 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
US6762201B1
(en)
|
1999-10-08 |
2004-07-13 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
ECSP003699A
(es)
|
1999-10-08 |
2002-04-23 |
Smithkline Beecham Corp |
Inhibidores de fab i
|
|
DE60019954T2
(de)
|
1999-10-08 |
2006-02-23 |
Affinium Pharmaceuticals, Inc., Toronto |
Fab i hemmer
|
|
DE60029235T2
(de)
|
1999-10-08 |
2007-06-14 |
Affinium Pharmaceuticals, Inc., Toronto |
Fab-i-hemmer
|
|
CA2323008C
(en)
|
1999-10-11 |
2005-07-12 |
Pfizer Inc. |
Pharmaceutically active compounds
|
|
EP1227096B1
(en)
|
1999-10-19 |
2004-09-22 |
Sato Pharmaceutical Co. Ltd. |
4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure
|
|
US6951729B1
(en)
|
1999-10-27 |
2005-10-04 |
Affinium Pharmaceuticals, Inc. |
High throughput screening method for biological agents affecting fatty acid biosynthesis
|
|
CN1188111C
(zh)
|
1999-10-29 |
2005-02-09 |
耐科塔医药公司 |
分散性得到改进的干粉组合物
|
|
US6531291B1
(en)
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
|
US6514986B2
(en)
|
2000-11-22 |
2003-02-04 |
Wockhardt Limited |
Chiral fluoroquinolone arginine salt forms
|
|
US6656703B1
(en)
|
1999-12-29 |
2003-12-02 |
Millennium Pharamaceuticals, Inc. |
High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
|
|
US6372752B1
(en)
|
2000-02-07 |
2002-04-16 |
Genzyme Corporation |
Inha inhibitors and methods of use thereof
|
|
ES2179729B1
(es)
|
2000-03-23 |
2003-12-16 |
Dreiman Lab Farmaceuticos S A |
Forma farmaceutica solida de administracion oral dispersable en agua, que comprende rifampicina, isoniazida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
|
|
AU2000255628A1
(en)
|
2000-03-28 |
2001-10-08 |
Council Of Scientific And Industrial Research |
Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
|
|
JP2003531184A
(ja)
|
2000-04-21 |
2003-10-21 |
ローディア／カイレックス・インコーポレイテッド |
（ｒ）−１−（アリールオキシ）プロパン−２−オールの製造方法
|
|
WO2002007682A1
(en)
|
2000-07-26 |
2002-01-31 |
Vyden John K |
Methods for treating atopic disorders
|
|
DE10037029A1
(de)
|
2000-07-27 |
2002-02-28 |
Kugelstrahlzentrum Aachen Gmbh |
Verfahren und Vorrichtung zum Umformen von Strukturbauteilen
|
|
US6288239B1
(en)
|
2000-09-19 |
2001-09-11 |
Board Of Trustees Operating Michigan State University |
5-trityloxymethyl-oxazolidinones and process for the preparation thereof
|
|
WO2002025700A2
(en)
|
2000-09-21 |
2002-03-28 |
Cambridge Semiconductor Limited |
Semiconductor device and method of forming a semiconductor device
|
|
US6821746B2
(en)
|
2000-10-06 |
2004-11-23 |
Affinium Pharmaceuticals, Inc. |
Methods of screening for FabK antagonists and agonists
|
|
US7048926B2
(en)
|
2000-10-06 |
2006-05-23 |
Affinium Pharmaceuticals, Inc. |
Methods of agonizing and antagonizing FabK
|
|
HUP0400651A2
(hu)
|
2000-11-07 |
2004-06-28 |
Bristol-Myers Squibb Company |
Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
|
WO2002048097A1
(en)
|
2000-12-12 |
2002-06-20 |
Corvas International, Inc. |
Compounds, compositions and methods for treatment of parasitic infections
|
|
US6388070B1
(en)
|
2001-01-05 |
2002-05-14 |
Orchid Chemicals & Pharmaceuticals Ltd. |
Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
|
|
US6495158B1
(en)
|
2001-01-19 |
2002-12-17 |
Lec Tec Corporation |
Acne patch
|
|
PA8539401A1
(es)
|
2001-02-14 |
2002-10-28 |
Warner Lambert Co |
Quinazolinas como inhibidores de mmp-13
|
|
DE60230934D1
(de)
|
2001-04-06 |
2009-03-05 |
Affinium Pharm Inc |
Fab-i-inhibitoren
|
|
US6503906B1
(en)
|
2002-02-21 |
2003-01-07 |
Ren-Jin Lee |
Method for optimizing ciprofloxacin treatment of anthrax-exposed patients according to the patient's characteristics
|
|
MXPA04009580A
(es)
|
2002-04-02 |
2005-05-27 |
Tsumura & Co |
Inhibidor de fosfodiesterasa iv que contiene un derivado de piridilacrilamida.
|
|
WO2004014869A2
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
|
|
EP1575951B1
(en)
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterocyclic compounds, methods of making them and their use in therapy
|
|
WO2004082586A2
(en)
|
2003-03-17 |
2004-09-30 |
Affinium Pharmaceuticals, Inc. |
Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
|
|
US7745625B2
(en)
|
2004-03-15 |
2010-06-29 |
Bristol-Myers Squibb Company |
Prodrugs of piperazine and substituted piperidine antiviral agents
|
|
US8450307B2
(en)
|
2004-06-04 |
2013-05-28 |
Affinium Pharmaceuticals, Inc. |
Therapeutic agents, and methods of making and using the same
|
|
CN101115761B
(zh)
|
2005-01-19 |
2012-07-18 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物的前药及其应用
|
|
CN101415701A
(zh)
*
|
2005-12-05 |
2009-04-22 |
Affinium医药公司 |
作为fabi抑制剂的杂环丙烯酰胺化合物和抗菌剂
|
|
CA2632476A1
(en)
|
2005-12-05 |
2007-06-14 |
Affinium Pharmaceuticals, Inc. |
Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
|
|
EP2687533B1
(en)
|
2006-07-20 |
2017-07-19 |
Debiopharm International SA |
Acrylamide derivatives as FAB I inhibitors
|
|
EP2420505A1
(en)
|
2006-11-21 |
2012-02-22 |
Rigel Pharmaceuticals, Inc. |
Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
|
|
WO2008098374A1
(en)
*
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
|
US20090012045A1
(en)
|
2007-06-26 |
2009-01-08 |
Rigel Pharmaceuticals, Inc. |
Methods of Treating Cell Proliferative Disorders
|
|
AU2010266018B2
(en)
*
|
2009-06-25 |
2014-01-09 |
Alkermes Pharma Ireland Limited |
Heterocyclic compounds for the treatment of neurological and psychological disorders
|
|
US8686009B2
(en)
*
|
2009-06-25 |
2014-04-01 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds
|
|
UA108077C2
(xx)
|
2009-07-02 |
2015-03-25 |
|
Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
|
|
WO2011061214A1
(en)
*
|
2009-11-18 |
2011-05-26 |
Fab Pharma Sas |
Novel heterocyclic acrylamides and their use as pharmaceuticals
|
|
EP2579863A4
(en)
|
2010-06-11 |
2013-11-27 |
Affinium Pharm Inc |
COMPOUNDS FOR THE TREATMENT OF BOVINE MASTITIS
|
|
CN102675311A
(zh)
|
2011-06-14 |
2012-09-19 |
苏春华 |
一种氟代丙烯酰胺的衍生物
|
|
WO2013080222A1
(en)
|
2011-12-02 |
2013-06-06 |
Aurigene Discovery Technologies Limited |
Substituted pyridine derivatives as fabi inhibitors
|
|
KR101720885B1
(ko)
|
2012-06-19 |
2017-03-28 |
데비오팜 인터네셔날 에스 에이 |
(e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
|